Author Correction: Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses

Nat Commun. 2021 Oct 14;12(1):6090. doi: 10.1038/s41467-021-26418-1.

Gabriela Alvarado^#¹, Wilhelm Salmen^#², Khalil Ettayebi², Liya Hu³, Banumathi Sankaran⁴, Mary K Estes^{2

5}, B V Venkataram Prasad^{6

7}, James E Crowe Jr^{8

9

10}

¹ Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
² Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
³ The Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA.
⁴ Berkeley Center for Structural Biology, Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley Laboratory, Berkeley, CA, USA.
⁵ Department of Medicine-Gastroenterology and Hepatology, Baylor College of Medicine, Houston, TX, USA.
⁶ Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA. vprasad@bcm.edu.
⁷ The Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA. vprasad@bcm.edu.
⁸ Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.
⁹ The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.
¹⁰ Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.

^# Contributed equally.

No abstract available

Publication types